Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.

about

Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.

P2860

Q55233801-DCF883EF-E372-420A-B9E7-FEDF4E7D7E51

P2860

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.

Item

http://www.wikidata.org/entity/Q46989239

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@en

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@nl

type

Item

label

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@en

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@nl

prefLabel

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@en

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@nl

P1476

Postoperative Outcomes in Uste ...... perations for Crohn's Disease.

@en

P2093

Amy L Lightner

http://www.w3.org/2001/XMLSchema#string

Andre D'Hoore

http://www.w3.org/2001/XMLSchema#string

Chung Sang Tse

http://www.w3.org/2001/XMLSchema#string

Francesca DiCandido

http://www.w3.org/2001/XMLSchema#string

Gayane Ovsepyan

http://www.w3.org/2001/XMLSchema#string

Kellie L Mathis

http://www.w3.org/2001/XMLSchema#string

Kristen Crowell

http://www.w3.org/2001/XMLSchema#string

Laura E Raffals

http://www.w3.org/2001/XMLSchema#string

Marc Ferrante

http://www.w3.org/2001/XMLSchema#string

Nathalie Lauwers

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Certolizumab pegol for the treatment of Crohn's disease

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery.

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.

Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.

P304

402-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX163

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonino Spinelli

Edward V Loftus

Bram Verstockt

P577

2017-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29220430

http://www.w3.org/2001/XMLSchema#string

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.

about

P2860

P2860

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698